MS-1901 HIEstem Cell Therapeutics(Medinno)

N/A

Report date: 2024/01/25 16:16:56

Base Information

Drug NameMS-1901 HIEstem Cell Therapeutics(Medinno)
Drug Alias NameMS-1901MS1901
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsHypoxia-Ischemia, Brain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedinno Inc
China Registration ClassN/A

Develop Information

Active CompaniesMedinno Inc
Inactive CompaniesN/A
Active IndicationsHypoxia-Ischemia, Brain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A